Professional Documents
Culture Documents
3 Endocrine
3 Endocrine
GD
N.B. Only regular insulin can be given by intravenous route
10
• Examples of recommended insulin regimens
Short acting insulin mixed with intermediate - acting insulin: twice
daily (before meals) Mixed NPH and regular insulin -70/30 (70% NPH & 30% regular)
Short acting insulin mixed with intermediate acting insulin before
breakfast: Short-acting insulin before evening meal; and Intermediate-
acting insulin: at bed time
Short-acting insulin: three times daily (before breakfast, midday and
evening meal)
Intermediate - acting insulin at bedtime
Intermediate-acting insulin with or without short-acting insulin once
daily either before breakfast or at bedtime suffices for some patients
with type II diabetes who need insulin, sometimes in combination with
oral hypoglycemic drugs.
• Indication:
Treatment of type I DM,
Treatment of type II DM not controlled by other agents
Management of diabetic ketoacidosis
Control of diabetes in pregnancy, during surgery and in
infections
• Adverse Reaction and complication:
• Hypoglycemia (reduced blood glucose)
• Hypertrophy (increase size) at site of injection
– Hypersensitivity reaction (insulin allergy)
Oral hypoglycemic drugs
MOA:increase insulin secretion
• These are antidiabetic drugs administered orally 30 minutes
before meal
• They lower blood glucose level and used in mild diabetes
Glibenclamide (Tablet, 5mg): 2.5 mg/d-20 mg/d
Glipizide: Tablet, 2.5mg, 5mg, 10mg
Glimperide: Tablet, 1mg, 2mg, 4mg
Side effect :hypoglycemia ,weight gain
Biguanides
MOA: work by preventing the production of glucose in the liver,
improving the body’ssensitivity towards insulin receptor
They potentiate the hypoglycemic action of insulin and
sulphonylureas
The only commercially available biguanides is metformin.
Metformin (500mg-1000mg bid after meal) is effective as
monotherapy (alone) and in combination with nearly every other
therapy for type 2 diabetes
Combinations of metformin in conjunction with glipizide, and
glyburide are available
ADE:Nausea, vomiting, stomach upset, diarrhea, gas, weakness, or
a metallic taste in the mouth may occured
Anti-thyroid drugs
13-Jan-24
Anti-thyroid drugs
• The normal thyroid gland secretes sufficient
amounts of the thyroid hormones
triiodothyronine (T3) and tetraiodothyronine (T4,
thyroxine)
– to normalize growth and development, body
temperature, and energy levels.
GD
• Hypothalamic Thyroid-releasing hormone
(TRH) stimulates
• Pituitary
– Thyroid-stimulating hormone (TSH) release,
16
13-Jan-24
CONT…
• TSH stimulates T4and T3 synthesis and
release from the thyroid, and they in turn
inhibit both TRH and TSH synthesis and
release.
GD
17
hyperthyrodism
• Weight loss despite increased appetite
• Excessive sweating
• Heat intolerance
• Palpitations( increase heart rate)
• Menstrual irregularity , mainly
oligomenorrhea
• Increased hair loss
• In thyroiditis there could be neck pain
hypothyrodism
• Intolerance to cold environments,
constipation
• weight gain
• hair loss
• dry skin
• Hoarse voice
• lethargy, memory loss, depressed
reflexes(decrease heart rate)
13-Jan-24
Thyroid hormones and anti-thyroid
I. Thyroid hormone preparations include:
thyroxine sodium
– Used in hypothyroidism (reduced secretion of
thyroid hormones)
II. Anti-thyroid drugs include:
GD
– Propylthiouracil(less cross placenta), methimazole,
carbimazole, Lugol‘s iodine, potassium iodide,
propranolol, metoprolol
21
13-Jan-24
Anti-thyroid and thyroid preparations with their specific indication
during pregnancy
GD
asthmatic patients
100mg carbimazole in
pregnancy